Fast-paced Momentum Stock Petco (WOOF) Is Still Trading at a Bargain

Zacks Investment Research highlights a "Fast-Paced Momentum at a Bargain" investment strategy, which targets stocks exhibiting strong recent price momentum while maintaining attractive valuations. Petco Health & Wellness (WOOF) is presented as a key example, having delivered 5.3% growth in four weeks and 14.2% in twelve weeks with a beta of 1.74, and earning a Zacks Rank #1 (Strong Buy) due to upward earnings estimate revisions. Notably, WOOF trades at a low price-to-sales ratio of 0.18, suggesting it offers significant upside potential by combining momentum with a reasonable valuation, thereby mitigating risks associated with overvalued growth stocks.

Analysis

Petco Health & Wellness (WOOF) is being highlighted as a prime example of a 'Fast-Paced Momentum at a Bargain' investment thesis, which seeks to combine strong price momentum with an attractive valuation. The stock exhibits significant recent momentum, evidenced by a 5.3% price increase over the past four weeks and a 14.2% gain over the last twelve weeks. This price action is supported by a Zacks Momentum Score of 'B'. The stock's high-risk, high-reward nature is underscored by a beta of 1.74, indicating it is 74% more volatile than the broader market. Fundamentally, the momentum appears driven by upward revisions in earnings estimates, which have secured the stock a Zacks Rank #1 (Strong Buy). Despite this strong performance and bullish analyst sentiment, the stock is presented as undervalued based on a Price-to-Sales (P/S) ratio of 0.18, suggesting investors pay only 18 cents for every dollar of sales. This combination of positive technicals and a low valuation metric forms the core of the bullish argument, positioning WOOF as a stock with potential for continued upside without the typical risks of an over-inflated valuation.

Key Decisions for Investors

• Investors pursuing momentum strategies should consider Petco (WOOF) due to its combination of strong recent price performance and a low Price-to-Sales ratio of 0.18, which may offer a more favorable risk/reward profile than purely momentum-driven, high-valuation stocks.
• Given the stock's high beta of 1.74, portfolio managers should be prepared for significant volatility and may want to size positions accordingly, while noting that the upward earnings revisions provide a fundamental justification for the bullish momentum.
• It is crucial to monitor for continued positive earnings estimate revisions, as the article identifies this factor as the primary catalyst sustaining investor interest and the stock's Zacks Rank #1 status.